"The probe report submitted to the state government have found no fault of ministers in purchase and supply of medicines to government hospitals," Manjhi told reporters.
"Action has been taken against ten officials and there is no need for further action against anyone," he said.
When Health Minister Ramdhani Singh's comments was sought on whether more action would be taken by the state government, he said, "I don't not know about the probe report. I am like a letter box... Whatever (file) comes to me, I clear it. I come to know about things after action is already initiated."
Interestingly, both Manjhi and Singh were talking to reporters on the sidelines of a "Janata ke Darbar mein Mukhya Mantri" programme.
Opposition BJP has been extremely critical over purchase and supply of "substandard" medicines at a higher price by a government appointed committee to government hospitals.
The issue came to light when a patient hailing from Banka died in Bhagalpur after being administered medicines early this year.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
